HealthWHO urges Ervebo vaccine trial amid DR Congo Ebola outbreak

WHO vaccine experts recommended on Friday that researchers conduct a full-scale human trial of Ervebo, the only Ebola vaccine currently approved. The study would examine whether it can provide cross-protection against a deadly strain spreading in the Democratic Republic of Congo. The recommendation comes as health officials assess the vaccine’s usefulness against that strain. Its focus is on determining the extent of protection Ervebo may offer.